Bror Thomas Pollare
Chairman at ALZECURE PHARMA AB
Profile
Bror Thomas Pollare was the founder and the Chief Executive Officer of Global Medical Investments GMI AB, founded in 2009.
He is also the founder of Oncolution AB.
Dr. Pollare's current jobs include Chairman at AlzeCure Pharma AB, Chairman at Ac Intressenter AB, Chairman at Sinfonia Biotherapeutics AB, Chairman at Alzecure Discovery AB, Chairman at Alzecure Foundation, Chairman at A3P Biomedical AB, Director at Carmel Pharma AB, Director at Psilox AB, Director at Pharmaceuticals Sales & Development AB, and Director at Premalux AB.
Dr. Pollare's former jobs include Chairman at QuiaPEG Pharmaceuticals AB, Chairman at Quiapeg Pharmaceuticals Holding AB, Chairman at Bio-Works Technologies AB (2017-2019), Director at Gyros AB, Director-Supervisory Board at Trigen Holdings AG (2009), Director at Xellia Pharmaceuticals ApS, Director at Premacure AB, Director at Centro Gamma Knife Santiago Sap, Director at Cereno Scientific AB (2016-2018), Director at SSI Diagnostica.
A (2016-2022), Director at Premacure Holding AB, Director at Gamma Knife Center Ecuador SA, Director at PT Gammaknife Center Indonesia, Director at Cancun Oncology Center S.
A P I De C V Mexico, Director at Center Oncologico Y De Radioterapia Tec 100 S A P I De C V, Director at Sweden Ghana Medical Center Ltd., Director at Centro De Neuro Radiocirugia San Javier Gamma Knife SA de CV, Director at Centro Gamma Knife Dominicana SRL, Vice President at Pharmacia Corp., Partner at 3i Plc, and Partner at 3i Nordic Plc (2002-2010).
Dr. Pollare's education includes a doctorate from Karolinska Institutet and a doctorate from the University of Uppsala.
Dr. Pollare is also the founder of Oncolution AB.
Bror Thomas Pollare active positions
| Companies | Position | Start |
|---|---|---|
| ALZECURE PHARMA AB | Chairman | 2016-12-31 |
Sinfonia Biotherapeutics AB
 Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Chairman | - |
| Alzecure Discovery AB | Chairman | - |
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Chairman | - |
| Alzecure Foundation | Chairman | - |
| Ac Intressenter AB | Chairman | - |
| Oncolution AB | Chief Executive Officer | - |
| Pharmaceuticals Sales & Development AB | Director/Board Member | - |
Psilox AB
 Psilox AB Medical SpecialtiesHealth Technology Psilox AB engages in the manufacture and application of bio ceramic materials. It offers calcium phosphate microspheres used in treatments in dentistry and medicine. The company was founded by Håkan Gunnar Engqvist and Wei Xia on May 29, 2013 and is headquartered in Uppsala, Sweden. | Director/Board Member | - |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Bror Thomas Pollare
| Companies | Position | End |
|---|---|---|
| ░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of Bror Thomas Pollare
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BIO-WORKS TECHNOLOGIES AB | Health Technology |
| CERENO SCIENTIFIC AB | Health Technology |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| ALZECURE PHARMA AB | Health Technology |
| Private companies | 30 |
|---|---|
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
3i Plc
 3i Plc Financial ConglomeratesFinance 3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom. | Finance |
Carmel Pharma AB
 Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden. | Electronic Technology |
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Trigen Holdings AG develops drugs focusing on thrombosis and vascular dysfunction. Its product pipeline includes clinical stage candidates, TGN 255, TGN 167 and PR-15. The company has offices in London. Trigen Holdings was founded in 2005 and is headquartered in Martinsried, Germany. | Commercial Services |
3i Nordic Plc
 3i Nordic Plc Investment ManagersFinance 3i Nordic Plc (3i Nordic) is the Swedish venture capital subsidiary of 3i Group Plc (LSE: III) in Great Britain. Formerly known as Atle AB, founded in 1993, the firm was acquired by 3i in 2001 and renamed 3i Nordic. Located in Stockholm, 3i Nordic utilizes specialized 3i Group resources to provide financial experience, sector knowledge, company management practice and access to 3i's network of international contacts to investee companies. 3i Nordic is part of the 3i Nordic investment team which includes investment professionals from the Helsinki and Copenhagen offices. | Finance |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Schering Plough, Inc. | |
Premacure AB
 Premacure AB Pharmaceuticals: MajorHealth Technology Premacure AB owns shares and acquires securities, patents, rights and licenses from other businesses. It is also involved in biotechnology and medicine. The company is headquartered in Stockholm, Sweden. | Health Technology |
| Premalux AB | |
Global Medical Investments GMI AB
 Global Medical Investments GMI AB Financial ConglomeratesFinance Global Medical Investments GMI AB establishes and operates cancer centers in developing countries. It engages in the development and support of cancer management programs and cancer treatment clinics. The firm is an investment and project development company. It also secures contracts with health insurance companies and healthcare providers for private and state-run companies and government insurance agencies. The company was founded by Bror Thomas Pollare on July 24, 2009 and is headquartered in Solna, Sweden. | Finance |
Psilox AB
Psilox AB Medical SpecialtiesHealth Technology Psilox AB engages in the manufacture and application of bio ceramic materials. It offers calcium phosphate microspheres used in treatments in dentistry and medicine. The company was founded by Håkan Gunnar Engqvist and Wei Xia on May 29, 2013 and is headquartered in Uppsala, Sweden. | Health Technology |
QuiaPEG Pharmaceuticals AB
 QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
SSI Diagnostica A/S
 SSI Diagnostica A/S Medical SpecialtiesHealth Technology SSI Diagnostica A/S develops, produces, and sells in-vitro diagnostic products for clinical microbiology, veterinary diagnostics, food control, as well as environmental and hygiene control. The firm supplies a range of pneumococcal antigens and serotype specific capsular polysaccharides. The firm also markets antisera, bacterial strains, rapid tests, and animal blood products. The company was founded in 1998 and is headquartered in Hillerod, Denmark. | Health Technology |
| Oncolution AB | |
| Pharmaceuticals Sales & Development AB | |
| Ac Intressenter AB | |
Sinfonia Biotherapeutics AB
Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Health Technology |
| Alzecure Discovery AB | |
| Alzecure Foundation | |
| Premacure Holding AB | |
Gamma Knife Center Ecuador SA
 Gamma Knife Center Ecuador SA Hospital/Nursing ManagementHealth Services Gamma Knife Center Ecuador SA engages in the management of a healthcare institution. The firm specializes in the provision of stereotactic radiosurgery through a Gamma Knife unit to treat patients with tumors. The company was founded in 2009 and is headquartered in Guayaquil, Ecuador. | Health Services |
| PT Gammaknife Center Indonesia | |
| Cancun Oncology Center S A P I De C V Mexico | |
| Center Oncologico Y De Radioterapia Tec 100 S A P I De C V | |
| Sweden Ghana Medical Center Ltd. | |
| Centro De Neuro Radiocirugia San Javier Gamma Knife SA de CV | |
| Centro Gamma Knife Dominicana SRL | |
A3P Biomedical AB
A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Health Services |
| Centro Gamma Knife Santiago Sap |
- Stock Market
- Insiders
- Bror Thomas Pollare
